Recent progress and concerns regarding the Japanese immunization program: Addressing the “vaccine gap”

Highlights • Seven new vaccines (12 products) have been introduced in Japan since 2008. • The Japanese Immunization Law underwent major revision in 2013. • A recent rubella epidemic in Japan led to >40 cases of congenital rubella syndrome. • The HPV vaccine was temporarily withdrawn due to report...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2014-07, Vol.32 (34), p.4253-4258
Main Authors: Saitoh, Akihiko, Okabe, Nobuhiko
Format: Article
Language:English
Subjects:
Allergy and Immunology
Applied microbiology
Biological and medical sciences
Budgets
Chronic Pain - chemically induced
Congenital rubella syndrome
Conversion disorder
Developed countries
Epidemics
Fundamental and applied biological sciences. Psychology
Health Policy
Human papilloma virus vaccine
Human viral diseases
Humans
Immunization
Immunization program
Immunization Programs - legislation & jurisprudence
Immunization Programs - organization & administration
Industrialized nations
Infectious diseases
Japan
Licenses
Medical sciences
Microbiology
Papillomavirus Vaccines - adverse effects
Public health
Rubella
Rubella - epidemiology
Safety-Based Drug Withdrawals
Tetanus
Tuberculosis
Tumors
Vaccine gap
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Viruses
Whooping cough
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Seven new vaccines (12 products) have been introduced in Japan since 2008. • The Japanese Immunization Law underwent major revision in 2013. • A recent rubella epidemic in Japan led to >40 cases of congenital rubella syndrome. • The HPV vaccine was temporarily withdrawn due to reports of pain/motor impairment. • Some important vaccines are still categorized as voluntary vaccines in Japan.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2014.06.022